-
1 Comment
IntriCon Corporation is currently in a long term uptrend where the price is trading 0.8% above its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.1.
IntriCon Corporation's total revenue rose by 9.4% to $30M since the same quarter in the previous year.
Its net income has increased by 42.4% to $1M since the same quarter in the previous year.
Finally, its free cash flow grew by 555.7% to $5M since the same quarter in the previous year.
Based on the above factors, IntriCon Corporation gets an overall score of 5/5.
Industry | Medical Instruments & Supplies |
---|---|
ISIN | US46121H1095 |
Sector | Healthcare |
CurrencyCode | USD |
Exchange | NASDAQ |
Target Price | 25 |
---|---|
Dividend Yield | 0.0% |
Beta | 1.01 |
Market Cap | 225M |
PE Ratio | None |
IntriCon Corporation, together with its subsidiaries, designs, develops, engineers, manufactures, and distributes body-worn devices in the United States, Europe, Asia, and internationally. It offers micro-miniature products, microelectronics, micro-mechanical assemblies, high-precision injection-molded plastic components, and assemblies and software solutions for medical devices, hearing healthcare, and professional audio communication devices markets. The company also provides micro coils for surgical navigation clinical applications, such as interventional pulmonology and electrophysiology; joint engineering and manufacturing services for complex medical devices, including catheters covering a range of applications for cardiology, peripheral vascular, neurology, radiology, and pulmonology; bubble sensors and flow restrictors that monitor and control the flow of fluid in an intravenous infusion system; and safety needle products for original equipment manufacturing customers. In addition, it offers professional audio headset products used for emergency response needs in the fire, law enforcement, safety, aviation, and military markets; and a line of miniature ear- and head-worn devices used by performers and support staff in the music and stage performance markets. The company sells its hearing device products, and medical and professional audio communications products directly to hearing instrument manufacturers, distributors, and partnerships; and microphone products to the radio communication and professional audio industries, as well as markets and sells hearing aid devices directly to consumers through direct mail advertising, Internet, and call center. The company was formerly known as Selas Corporation of America and changed its name to IntriCon Corporation. The company was incorporated in 1930 and is headquartered in Arden Hills, Minnesota.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for IIN using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024